BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29479867)

  • 1. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
    Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.
    Egger M; Spycher BD; Sidle J; Weigel R; Geng EH; Fox MP; MacPhail P; van Cutsem G; Messou E; Wood R; Nash D; Pascoe M; Dickinson D; Etard JF; McIntyre JA; Brinkhof MW;
    PLoS Med; 2011 Jan; 8(1):e1000390. PubMed ID: 21267057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
    Zürcher K; Mooser A; Anderegg N; Tymejczyk O; Couvillon MJ; Nash D; Egger M;
    Trop Med Int Health; 2017 Apr; 22(4):375-387. PubMed ID: 28102610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis.
    Wilkinson LS; Skordis-Worrall J; Ajose O; Ford N
    Trop Med Int Health; 2015 Mar; 20(3):365-79. PubMed ID: 25418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.
    Muhula S; Gachohi J; Kombe Y; Karanja S
    PLoS One; 2022; 17(2):e0263663. PubMed ID: 35139118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating retention in HIV care accounting for clinic transfers using electronic medical records: evidence from a large antiretroviral treatment programme in the Western Cape, South Africa.
    Bengtson AM; Colvin C; Kirwa K; Cornell M; Lurie MN
    Trop Med Int Health; 2020 Aug; 25(8):936-943. PubMed ID: 32406961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
    Kassanjee R; Johnson LF; Zaniewski E; Ballif M; Christ B; Yiannoutsos CT; Nyakato P; Desmonde S; Edmonds A; Sudjaritruk T; Pinto J; Vreeman R; Dahourou DL; Twizere C; Kariminia A; Carlucci JG; Kasozi C; Davies MA;
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25780. PubMed ID: 34546646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019.
    Chammartin F; Dao Ostinelli CH; Anastos K; Jaquet A; Brazier E; Brown S; Dabis F; Davies MA; Duda SN; Malateste K; Nash D; Wools-Kaloustian K; von Groote PM; Egger M
    BMJ Open; 2020 May; 10(5):e035246. PubMed ID: 32414825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa.
    Ross J; Brazier E; Fatti G; Jaquet A; Tanon A; Haas AD; Diero L; Castelnuovo B; Yiannoutsos CT; Nash D; Anastos KM; Yotebieng M
    Clin Infect Dis; 2023 Jan; 76(1):39-47. PubMed ID: 36097726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.
    Kariminia A; Law M; Davies MA; Vinikoor M; Wools-Kaloustian K; Leroy V; Edmonds A; McGowan C; Vreeman R; Fairlie L; Ayaya S; Yotebieng M; Takassi E; Pinto J; Adedimeji A; Malateste K; Machado DM; Penazzato M; Hazra R; Sohn AH;
    J Int AIDS Soc; 2018 Dec; 21(12):e25215. PubMed ID: 30548817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
    De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.
    Rosen S; Fox MP; Gill CJ
    PLoS Med; 2007 Oct; 4(10):e298. PubMed ID: 17941716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.